Lastly, a statistically significant exposure–response relationship between bosutinib exposure and the probability of Grade >2 severity was observed for thrombocytopenia, whereas no significant exposure–response relationship between bosutinib exposure and incidence for elevated ALT and neutropenia was observed. The gene discussed is GPT; the disease is Decreased total neutrophil count.